NM_032208.3:c.153-6819A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_032208.3(ANTXR1):c.153-6819A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.377 in 152,074 control chromosomes in the GnomAD database, including 16,312 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.38 ( 16312 hom., cov: 32)
Consequence
ANTXR1
NM_032208.3 intron
NM_032208.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0160
Publications
17 publications found
Genes affected
ANTXR1 (HGNC:21014): (ANTXR cell adhesion molecule 1) This gene encodes a type I transmembrane protein and is a tumor-specific endothelial marker that has been implicated in colorectal cancer. The encoded protein has been shown to also be a docking protein or receptor for Bacillus anthracis toxin, the causative agent of the disease, anthrax. The binding of the protective antigen (PA) component, of the tripartite anthrax toxin, to this receptor protein mediates delivery of toxin components to the cytosol of cells. Once inside the cell, the other two components of anthrax toxin, edema factor (EF) and lethal factor (LF) disrupt normal cellular processes. Three alternatively spliced variants that encode different protein isoforms have been described. [provided by RefSeq, Oct 2008]
ANTXR1 Gene-Disease associations (from GenCC):
- GAPO syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- capillary infantile hemangiomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.761 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.377 AC: 57249AN: 151956Hom.: 16254 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
57249
AN:
151956
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.377 AC: 57357AN: 152074Hom.: 16312 Cov.: 32 AF XY: 0.380 AC XY: 28245AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
57357
AN:
152074
Hom.:
Cov.:
32
AF XY:
AC XY:
28245
AN XY:
74324
show subpopulations
African (AFR)
AF:
AC:
31854
AN:
41488
American (AMR)
AF:
AC:
6006
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
694
AN:
3470
East Asian (EAS)
AF:
AC:
3469
AN:
5148
South Asian (SAS)
AF:
AC:
1667
AN:
4822
European-Finnish (FIN)
AF:
AC:
2268
AN:
10574
Middle Eastern (MID)
AF:
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10415
AN:
67974
Other (OTH)
AF:
AC:
665
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1266
2532
3799
5065
6331
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1705
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.